» Articles » PMID: 36753014

Established the First Clinical Prediction Model Regarding the Risk of Hyperuricemia in Adult IgA Nephropathy

Overview
Publisher Springer
Specialty Nephrology
Date 2023 Feb 8
PMID 36753014
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To construct a novel nomogram model that predicts the risk of hyperuricemia incidence in IgA nephropathy (IgAN).

Methods: Demographic and clinicopathological characteristics of 1184 IgAN patients in the First Affiliated Hospital of Zhengzhou University Hospital were collected. Univariate analysis and multivariate logistic regression were used to screen out hyperuricemia risk factors. The risk factors were used to establish a predictive nomogram model. The performance of the nomogram model was evaluated using an area under the receiver-operating characteristic curve (AUC), calibration plots, and a decision curve analysis.

Results: Independent predictors for hyperuricemia incidence risk included sex, hypoalbuminemia, hypertriglyceridemia, blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), 24 h urinary protein (24 h TP), gross hematuria and tubular atrophy/interstitial fibrosis (T). The nomogram model exhibited moderate prediction ability with an AUC of 0.834 (95% CI 0.804-0.864). The AUC from validation reached 0.787 (95% CI 0.736-0.839). The decision curve analysis displayed that the hyperuricemia risk nomogram was clinically applicable.

Conclusion: Our novel and simple nomogram containing 8 factors may be useful in predicting hyperuricemia incidence risk in IgAN.

Citing Articles

Risk prediction of hyperuricemia based on particle swarm fusion machine learning solely dependent on routine blood tests.

Fang M, Pan C, Yu X, Li W, Wang B, Zhou H BMC Med Inform Decis Mak. 2025; 25(1):131.

PMID: 40087711 DOI: 10.1186/s12911-025-02956-2.


One-Year Risk Prediction of Elevated Serum Uric Acid Levels in Older Adults: A Longitudinal Cohort Study.

Zhang D, Xu X, Ye Z, Zhang Z, Xiao J Clin Interv Aging. 2024; 19:1951-1964.

PMID: 39605933 PMC: 11600923. DOI: 10.2147/CIA.S476806.


Machine learning-based diagnosis and prognosis of IgAN: A systematic review and meta-analysis.

Zhuang K, Wang W, Xu C, Guo X, Ren X, Liang Y Heliyon. 2024; 10(12):e33090.

PMID: 38988582 PMC: 11234108. DOI: 10.1016/j.heliyon.2024.e33090.

References
1.
Rekola S, Bergstrand A, Bucht H . Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int. 1991; 40(6):1050-4. DOI: 10.1038/ki.1991.313. View

2.
Bakan A, Oral A, Elcioglu O, Takir M, Kostek O, Ozkok A . Hyperuricemia is associated with progression of IgA nephropathy. Int Urol Nephrol. 2015; 47(4):673-8. DOI: 10.1007/s11255-015-0939-7. View

3.
Moriyama T, Itabashi M, Takei T, Kataoka H, Sato M, Shimizu A . High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a. J Nephrol. 2014; 28(4):451-6. DOI: 10.1007/s40620-014-0154-0. View

4.
Zhu B, Yu D, Lv J, Lin Y, Li Q, Yin J . Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases. Am J Nephrol. 2018; 48(2):127-136. DOI: 10.1159/000489962. View

5.
Cheng G, Liu D, Zhang N, Tang L, Zhao Z, Liu Z . Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up. Clin Nephrol. 2013; 80(1):40-6. DOI: 10.5414/CN107813. View